Immunology and epilepsy

Reviews in Neurological Diseases

Volumn 5, Issue 3, 2008, Pages 109-116

  Najjar, Souhel ^a   Bernbaum, Melissa ^a   Lai, George ^a   Devinsky, Orrin ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epilepsy; Immunology; Microglia

Indexed keywords

ANTIBODY; POTASSIUM CHANNEL; POTASSIUM CHANNEL ANTIBODY; UNCLASSIFIED DRUG;

BRAIN VASCULITIS; CELL ACTIVATION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CROHN DISEASE; ENCEPHALITIS; ENCEPHALOMYELITIS; EPILEPSY; HASHIMOTO ENCEPHALOPATHY; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOPATHOLOGY; INFLAMMATION; LANDAU KLEFFNER SYNDROME; LENNOX GASTAUT SYNDROME; MICROGLIA; MULTIPLE SCLEROSIS; PARANEOPLASTIC LIMBIC ENCEPHALITIS; RASMUSSEN SYNDROME; RESEARCH; REVIEW; SARCOIDOSIS; SEIZURE; SJOEGREN SYNDROME; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TEMPORAL LOBE EPILEPSY;

AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; EPILEPSY; HUMANS; IMMUNE SYSTEM DISEASES; MICROGLIA;

EID: 53049083239     PISSN: 15452913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Callenbach PM, Geerts AT, Arts WF, et al. Familial occurrence of epilepsy in children with newly diagnosed multiple seizures: Dutch Study of Epilepsy in Childhood. Epilepsia. 1998;39:331-336.
2. Ottman R, Lee JH, Hauser WA, Risch N. Are generalized and localization-related epilepsies genetically distinct? Arch Neurol. 1998;55:339-344.
3. Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2008;58:1130-1135.
4. Carson MJ, Sutcliffe JG. Balancing function vs. self defense: the CNS as an active regulator of immune responses. J Neurosci Res. 1999;55:1-8.
5. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev. 1995;20:269-287.
6. Aloisi F. Immune function of microglia. Glia. 2001;36:165-179.
7. Mikdashi J, Krumholz A, Handwerger B. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus. Neurology. 2005;64:2102-2107.
8. González-Duarte A, Cantú-Brito CG, Ruano-Calderón L, García-Ramos G. Clinical description of seizures in patients with systemic lupus erythematosus. Eur Neurol. 2008;59:320-323.
9. Levite M, Ganor Y. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis. Expert Rev Neurother. 2008;8:1141-1160.
10. Kang EH, Shen GQ, Morris R, et al. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases. Lupus. 2008;17:21-25.
11. Alexander EL, Provost TT, Stevens MB, Alexander GE. Neurologic complications of primary Sjögren's syndrome. Medicine (Baltimore). 1982;61:247-257.
12. Elsehety A, Bertorini TE. Neurologic and neuropsychiatric complications of Crohn's disease. South Med J. 1997;90:606-610.
13. Delaney P. Seizures in sarcoidosis: a poor prognosis. Ann Neurol. 1980;7:494.
14. Kelley RE. CNS vasculitis. Front Biosci. 2004;9:946-955.
15. Lucchinetti CF, Gavrilova RH, Metz I, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008;131(Pt 7):1759-1775.
16. Calabrese M, De Stefano N, Atzori M, et al. Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J Neurol. 2008;255:581-586.
17. Spatt J, Chaix R, Mamoli B. Epileptic and non-epileptic seizures in multiple sclerosis. J Neurol. 2001;248:2-9.
18. Spatt J, Goldenberg G, Mamoli B. Simple dysphasic seizures as the sole manifestation of relapse in multiple sclerosis. Epilepsia. 1994;35:1342-1345.
19. Koch M, Uyttenboogaart M, Polman S, De Keyser J. Seizures in multiple sclerosis. Epilepsia. 2008;49:948-953.
20. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology. 2002;59:1224-1231.
21. Ishikawa N, Tajima G, Hyodo S, et al. Detection of autoantibodies against NMDA-type glutamate receptor in a patient with recurrent optic neuritis and transient cerebral lesions. Neuropediatrics. 2007;38:257-260.
22. Weng WC, Peng SS, Lee WT, et al. Acute disseminated encephalomyelitis in children: one medical center experience. Acta Paediatr Taiwan. 2006;47:67-71.
23. Lawn ND, Westmoreland BF, Kiely MJ, et al. Clinical, magnetic resonance imaging, and electroencephalographs findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003;78:1363-1368.
24. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(Pt 7):1481-1494.
25. Vernino S, Geschwind M, Boeve B. Autoimmune encephalopathies. Neurologist. 2007;13:140-147.
26. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25-36.
27. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127(Pt 3):701-712.
28. Majoie HJ, de Baets M, Renier W, et al. Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res. 2006;71:135-141.
29. Bien CG, Urbach H, Schramm J, et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology. 2007;69:1236-1244.
30. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001;50:73-78.
31. Samarasekera SR, Vincent A, Welch JL, et al. Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry. 2007;78:391-394.
32. Tamagno G, Federspil G, Murialdo G. Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto's encephalopathy). Intern Emerg Med. 2006;1:15-23.
33. Mayer T, Devinsky O. Seizures, cognitive abnormalities, and abnormal magnetic resonance imaging findings in a 19-year-old woman. Rev Neurol Dis. 2006;3:190; 195-197.
34. Pardo CA, Vining EP, Guo L, et al. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia. 2004;45:516-526.
35. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science. 1994;265:648-651.
36. Whitney KD, McNamara JO. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. J Neurosci. 2000;20:7307-7316.
37. Wiendl H, Bien CG, Bernasconi P, et al. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology. 2001;57:1511-1514.
38. Mantegazza R, Bernasconi P, Baggi F, et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol. 2002;131:179-185.
39. Levite M, Fleidervish IA, Schwarz A, et al. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel. J Autoimmun. 1999;13:61-72.
40. Yang R, Puranam RS, Butler LS, et al. Autoimmunity to munc-18 in Rasmussen's encephalitis. Neuron. 2000;28:375-383.
41. Riikonen R. The latest on infantile spasms. Curr Opin Neurol. 2005;18:91-95.
42. Haraldsson A, van Engelen BG, Renier WO, et al. Light chain ratios and concentrations of serum immunoglobulins in children with epilepsy. Epilepsy Res. 1992;13:255-260.
43. Cavazzuti GB. Infantile encephalopathies. Neurol Sci. 2003;24(suppl 4):S244-S245.
44. Plebani A, Duse M, Tiberti S, et al. Intravenous gamma-globulin therapy and serum IgG subclass levels in intractable childhood epilepsy. Monogr Allergy. 1988;23:204-215.
45. van Engelen BG, Renier WO, Weemaes CM, et al. Immunoglobulin treatment in epilepsy, a review of the literature. Epilepsy Res. 1994;19:181-190.
46. Deda G, Caksen H. Atypical benign partial epilepsy of childhood (pseudo-Lennox syndrome): report of two brothers. Neurol India. 2002;50:337-339.
47. Gross-Tsur V, Shalev RS, Kazir E, et al. Intravenous high-dose gammaglobulins for intractable childhood epilepsy. Acta Neurol Scand. 1993;88:204-209.
48. Mikati MA, Shamseddine AN. Management of Landau-Kleffner syndrome. Paediatr Drugs. 2005;7:377-389.
49. Sinclair DB, Snyder TJ. Corticosteroids for the treatment of Landau-Kleffner syndrome and continuous spike-wave discharge during sleep. Pediatr Neurol. 2005;32:300-306.
50. Sinclair DB. Prednisone therapy in pediatric epilepsy. Pediatr Neurol. 2003;28:194-198.
51. Tsuru T, Mori M, Mizuguchi M, Momoi MY. Effects of high-dose intravenous corticosteroid therapy in Landau-Kleffner syndrome. Pediatr Neurol. 2000;22:145-147.
52. Beach TG, Woodhurst WB, MacDonald DB, Jones MW. Reactive microglia in hippocampal sclerosis associated with human temporal lobe epilepsy. Neurosci Lett. 1995;191:27-30.
53. Boer K, Spliet WG, van Rijen PC, et al. Evidence of activated microglia in focal cortical dysplasia. J Neuroimmunol. 2006;173:188-195.
54. Ravizza T, Rizzi M, Perego C, et al. Inflammatory response and glia activation in developing rat hippocampus after status epilepticus. Epilepsia. 2005;46(suppl 5):113-117.
55. Eriksson C, Tehranian R, Iverfeldt K, et al. Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration. J Neurosci Res. 2000;60:266-279.
56. Rizzi M, Perego C, Aliprandi M, et al. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis. 2003;14:494-503.
57. Kanemoto K, Kawasaki J, Yuasa S, et al. Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia. 2003;44:796-799.
58. Jankowsky JL, Patterson PH. The role of cytokines and growth factors in seizures and their sequelae. Prog Neurobiol. 2001;63:125-149.
59. Vezzani A, Moneta D, Richichi C, et al. Functional role of inflammatory cytokines and anti-inflammatory molecules in seizures and epileptogenesis. Epilepsia. 2002;43(suppl 5):30-55.
60. Aarli JA. Role of cytokines in neurological disorders. Curr Med Chem. 2003;10:1931-1937.
61. Dubé C, Vezzani A, Behrens M, et al. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol. 2005;57:152-155.
62. Suzumura A, Takeuchi H, Zhang G, et al. Roles of glia-derived cytokines on neuronal degeneration and regeneration. Ann N Y Acad Sci. 2006;1088:219-229.
63. Jara JH, Singh BB, Floden AM, Combs CK. Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death. J Neurochem. 2007;100:1407-1420.
64. Siglienti I, Chan A, Kleinschnitz C, et al. Down-regulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions. J Neuropathol Exp Neurol. 2007;66:47-56.
65. Mander P, Brown GC. Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration. J Neuroinflammation. 2005;2:20.
66. Rimaniol AC, Haïk S, Martin M, et al. Na+-dependent high-affinity glutamate transport in macrophages. J Immunol. 2000;164:5430-5438.
67. Vallat-Decouvelaere AV, Chrétien F, Gras G, et al. Expression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients. A neuroprotective role for activated microglia? J Neuropathol Exp Neurol. 2003;62:475-485.
68. Beschorner R, Dietz K, Schauer N, et al. Expression of EAAT1 reflects a possible neuroprotective function of reactive astrocytes and activated microglia following human traumatic brain injury. Histol Histopathol. 2007;22:515-526.
69. Bano D, Nicotera P. Ca2+ signals and neuronal death in brain ischemia. Stroke. 2007;38(2 suppl):674-676.
70. Lehrmann E, Guidetti P, Löve A, et al. Glial activation precedes seizures and hippocampal neurodegeneration in measles virus-infected mice. Epilepsia. 2008;49(suppl 2):13-23.
71. Lemmens EM, Schijns OE, Beuls EA, Hoogland G. Cytogenesis in the dentate gyrus after neonatal hyperthermia-induced seizures: what becomes of surviving cells? Epilepsia. 2008;49:853-860.